Europe is emerging as an attractive route to global market access for Chinese sponsors. Early consideration of EMA requirements can help avoid costly delays and improve approval success. Read the article: https://ow.ly...

Every successful clinical trial starts long before the first participant is enrolled. Site Selection and Activation is one of the most important, yet often overlooked, stages of clinical research. From identifying the r...

Preparing for Italy's new serialisation framework requires more than regulatory awareness. Marketing authorisation holders, manufacturers and supply chain partners will need to assess packaging configurations, validate ...

Regulatory pathways for biosimilars are changing, with reduced clinical requirements placing greater emphasis on analytical comparability and manufacturing excellence. Understanding how to respond to these shifts can mak...

As biotech confidence returns and deal activity accelerates, companies have an opportunity to position themselves for the next phase of growth. In a new BioPharma Dive article, Deepali Suri, President of ICON Biotech, s...

We are proud to share that ICON has been named a Winner for Organisational Excellence for the second year running at the GCC India Workplace Innovation Summit & Awards 2026. This recognition celebrates organisations red...

Vaccines save millions of lives each year and help protect communities from preventable diseases. In support of National Immunisation Awareness Month, ICON is proud to have participated in 147 vaccine studies across key ...

Policy binders aren't enough to protect patients on neurologic monoclonal antibodies (mAbs). Clinical practices must embed automated safety rules, like therapy holds for active infections, directly into EHR systems. Disc...

Heart failure affects millions of people worldwide and can significantly impact quality of life. Research into new treatment approaches remains critical to improving outcomes and expanding options for patients living wit...

Colleagues at our Mexico office put their gaming skills to the test earlier this month at the ICON4U Super Smash Bros. Ultimate Tournament. Organised by the ICON4U Engagement and Celebrations Chapter, the event welcomed...

ctDNA holds significant potential for accelerating cancer drug development, but acceptance as a primary surrogate endpoint remains a major regulatory challenge. ICON’s Bea Mann examines the scientific, regulatory and evi...

Modern Alzheimer's management requires an "MRI metronome". For anti-amyloid therapies, rigid adherence to routine MRI schedules is essential to detect dangerous amyloid-related imaging abnormalities (ARIA). Read our arti...